You may also like
Baxter Initiates Worldwide Voluntary Recall Of Select Lots Of 5 percent Dextrose Injection, USP And 0.9 percent Sodium Chloride Injection, USP Intravenous (IV) Solutions
Baxter International Inc. announced today it has initiated a voluntary recall to the hospital/user level of one lot of 5 percent Dextrose Injection, USP and four lots of 0.9 percent Sodium Chloride Injection, USP due to particulate matter found in the solutions. Injecting a product containing particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack or damage to other organs such as the kidney or liver.
Tranexamic Acid and Aprotinin in Low and Intermediate-Risk Cardiac Surgery: A Non-Sponsored, Double-Blind, Randomised, Placebo-Controlled Trial
We wanted to compare the effectiveness of tranexamic acid versus aprotinin in reducing postoperative blood loss and transfusion requirements in the patient group representing the majority of cardiac surgery patients: low- and intermediate-risk patients.
Looking for Sponsors
Editors Note: CircuitSurfers is looking for sponsors and donations for the site. ‘Surfers remains a free site to all perfusionists and healthcare […]